Featured
-
-
Original Article |
AAV1/2-mediated BDNF gene therapy in a transgenic rat model of Huntington’s disease
- B Connor
- , Y Sun
- & C Maucksch
-
Original Article |
In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice
- P Conforti
- , A Mas Monteys
- & E Cattaneo
-
Short Communication |
Axonal transport of adeno-associated viral vectors is serotype-dependent
- E A Salegio
- , L Samaranch
- & K S Bankiewicz
-
Review |
Using non-coding small RNAs to develop therapies for Huntington's disease
- Y Zhang
- & R M Friedlander
-
Short Communication |
BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease
- A Giralt
- , H C Friedman
- & J Alberch